
Lupin Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "Lupin Launches Favipiravir Drug Covihalt�� for Treatment of Mild to Moderate COVID-19".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated August 05, 2020, titled "Lupin Launches Favipiravir Drug Covihalt�� for Treatment of Mild to Moderate COVID-19".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin